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Histo-blood group antigensisto-blood group antigen (HBGA) receptors in a strain-speciﬁc manner probably
detecting subtle structural differences in the carbohydrate receptors. The speciﬁc recognition of types A and
B antigens by various norovirus strains is a typical example. The only difference between the types A and B
antigens is the acetamide linked to the terminal galactose of the A but not to the B antigen. The crystal
structure of the P dimer of a GII-4 norovirus (VA387) bound to types A and B trisaccharides has elucidated
the A/B binding site on the capsid but did not explain the binding speciﬁcity of the two antigens. In this
study, using site-directed mutagenesis, we have identiﬁed three residues on the VA387 capsid that are
sterically close to the acetamide and are required for binding to A but not B antigens, indicating that the
acetamide determines the binding speciﬁcity between the A and B antigens. Further mutational analysis
showed that a nearby open cavity may also be involved in binding speciﬁcity to HBGAs. In addition, a
systematic mutational analysis of residues in and around the binding interface has identiﬁed a group of
amino acids that are required for binding but do not have direct contact with the carbohydrate antigens,
implying that these residues may be involved in the structural integrity of the receptor binding interface.
Taken together, our study provides new insights into the carbohydrate/capsid interactions which are a
valuable complement to the atomic structures in understanding the virus/host interaction and in the future
design of antiviral agents.
© 2008 Elsevier Inc. All rights reserved.IntroductionNoroviruses, a group of single-stranded, positive sense RNAviruses
within the family Caliciviridae, are the major viral pathogens of
epidemics of acute gastroenteritis worldwide. The norovirus capsid is
composed of 180 monomers of the capsid protein that organizes into
90 dimers (Prasad et al., 1999). The capsid protein can be divided into
two principle domains, the S domain constitutes the interior
icosahedral shell, while the P domain forms an arch-shaped protru-
sion emanating from the shell. The P domain can be further divided
into P1 and P2 subdomains, with the P2 subdomain located at the
outer surface of the viral capsid. The primary sequence of the P2
subdomain is highly variable among norovirus strains, suggesting its
involvement in host interaction. Expression of the P domain in vitroseases, Cincinnati Children's
ti, OH 45229-3039, USA. Fax:
er.
l rights reserved.results in dimerization (P dimer) and the formation of P particles that
retain HBGA-binding function (Tan, Hegde, and Jiang, 2004; Tan,
Meller, and Jiang, 2006; Tan and Jiang, 2005b). The involvement of the
P2 subdomain in receptor binding has been conﬁrmed bymutagenesis
and crystallographic studies (Bu et al., 2008; Cao et al., 2007; Tan et al.,
2003).
Noroviruses recognize human histo-blood group antigens (HBGAs)
as receptors, in a strain-speciﬁc manner [Reviewed in (Tan and Jiang,
2005a; Tan and Jiang, 2007)]. Eight distinct HBGA-binding patterns of
noroviruses have been described (Huang et al., 2003; Huang et al.,
2005). Strain VA387 belongs to GII-4 genotype that is predominant in
many countries (Ramirez et al., 2008; Siebenga et al., 2008; Tu et al.,
2008; Verhoef et al., 2008). VA387 represents one of the eight receptor
binding patterns and binds to A, B and H antigens. Other HBGA-
binding patterns include the H and A binders of Norwalk virus and
C59, the A binder of BUDS, the B binder of SnowMountain virus, the A
and B binder of MOH and etc (Huang et al., 2005). Human HBGAs are
complex carbohydrates that are composed of 3–8 monosaccharides
linked to proteins or lipids on the surface of red blood cells and
mucosal epithelia of the respiratory, genitourinary, and digestive
Fig. 1. The HBGA-binding interface of the norovirus capsid of VA387 (GII-4) interacting
with the type A- and B-trisaccharides. The binding interfaces in (A) and (B) are in
surface representation. The A- and B-trisaccharides are shown in stick representation,
with nitrogen, oxygen, and carbon atoms colored blue, red, and cyan (A-antigen) or
green (B-antigen), respectively. The saccharides are indicated as 1=α-1,2-fucose, 2=α-
1,3-N-acetylgalactoseamine, 2′=α-1,3-galactose, 3=β-1,3-galactose. The star symbol
indicates the junction linking to the remaining portion of the antigen. The white arrow
shows acetamide group in (A). The nearby open pocket is shown in green at the top-left
corner. (C) schematically shows hydrogen bonds (doted lines) between the individual
saccharides of the B-trisaccharide and the nearby amino acids of the capsid. The water-
bridged hydrogen bonds are indicated by W. (A) and (B) were prepared by software
PyMOL version 1.0 (Delano Scientiﬁc), while (C) by software ChemDraw Pro version 11.0
(Adept Scientiﬁc).
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HBGAs are highly polymorphic and three major HBGA families,
namely the ABO, Lewis, and secretor families, are involved in
norovirus recognition (Tan and Jiang, 2005a; Tan and Jiang, 2007).
Direct evidence linking HBGAs to norovirus infections and illness has
been obtained in volunteer studies by challenging with Norwalk virus
(Hutson et al., 2005; Hutson et al., 2002; Lindesmith et al., 2003).
Outbreak studies of GII-4 viruses also support this linkage (Tan et al.,
2008; Thorven et al., 2005). However, such evidence for other strains
representing other receptor binding patterns remains lacking.
Recently, the 2.0 Å crystal structures of the P dimer of VA387
complexed with the type A-{α-L-fucose-(1,2)-[α-D-acetylgalactosa-
mine-(1,3)]-D-galactose} and type B-{α-L-fucose-(1,2)-[α-D-galactose-
(1,3)]-D-galactose} trisaccharides, respectively, have been determined
(Cao et al., 2007) (Fig. 1). This has led to the identiﬁcation of the HBGA-
binding interface on the outermost P2 surface and the recognition of
the importance of dimerization of the P domain in the receptor
binding. The crystal structure revealed an extensive hydrogen-
bonding network between the trisaccharides and the nearby amino
acid residues of the receptor-binding interface. Three groups of amino
acids, each interacting with different sugars of the trisaccharide, have
been described (Cao et al., 2007). Although both the A- and the B-
trisaccharides were observed to bind to the same open pocket, the
crystal structures did not provide detailed information on the
binding speciﬁcity of noroviruses to HBGAs. In fact, no direct
interaction was observed between P domain and the acetamide of
the A-trisaccharide, the only structural difference between the A and
the B antigens (Cao et al., 2007).
In this study, we performed systematic mutagenesis to explore the
binding speciﬁcity of the HBGA-binding interface of VA387 and
identiﬁed a site deﬁned by three amino acids (Q331, K348, and I389) that
are sterically close to the acetamide of the A antigen and that is
required for binding to A- but not to the B-antigens, suggesting the
involvement of the site generated by these residues in interactions
with the acetamide of the A antigen. Similar effects were also
observed in a nearby open cavity. In addition, a group of other residues
that do not have direct contact with HBGAs but are required for
binding has been identiﬁed. These new data provide important
insights into the carbohydrate/capsid interactions andwould be useful
for future antiviral design against noroviruses.
Results
Evidence for the role of the acetamide of the A antigen in
norovirus-HBGA binding speciﬁcity
Our study beganwith the characterization of the site on the capsid
interacting with theα-1,3-glactose of the B-trisaccharide as suggested
by the crystal structure (Cao et al., 2007). The A- and B-antigens are
structurally identical except for the presence of an acetamide group at
the terminal sugar α-1,3-N-acetylgalactosamine of the A-antigen, but
not the α-1,3-glactose of the B-antigen (Fig. 1). Three amino acids
(A346, S441, and K348) were predicted to interact via solvent molecules
with theα-1,3-glactose of the B-antigen based on the crystal structure
(Cao et al., 2007) (Fig. 1). Mutations A346S and S441A completely
prevented binding of the mutant P particles to all A-, B-, and H-
antigens (Figs. 2B and D, Table 1), indicating that these two residues
are critical for binding to both A and B antigens. However, the third
mutation (K348A) resulted in complete loss of binding to the A- but did
not affect binding to the B-antigen in both saliva- and synthetic
oligosaccharide-based binding assays (Figs. 2C and I, Table 1),
suggesting that this residue is involved in the binding speciﬁcity to
the A antigen. The crystal structure of the HBGA-binding interface (Fig.
1) indicates that residue K348 is positioned away from the center of the
binding interface, close to the acetamide of the A-antigen, although no
direct interaction between the acetamide and K348 is seen (Cao et al.,2007). Interestingly, replacement of two other residues (Q331 and I389)
in the vicinity of K348 (Fig. 1) with alanines also resulted in the loss of
binding to the A- but not B- antigen (Figs. 2E–F, J–K; Table 1). These
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Table 1
Summary of the systematic mutagenesis analysis on residues in and around the HBGA-
binding interface of VA387 norovirus
Mutantsc Relative binding afﬁnity to HBGAsa
P particlesb P dimers
O A B O A B
Wild type + ++++ ++++ + ++ ++
The α-fucose-binding site:
T344A⁎ + ++++ ++++ + ++ ++
R345A⁎ − − − − − −
A346S⁎ − − − / / /
N373A − − − / / /
D374A⁎ − − − − − −
C440A⁎ + ++++ ++++ + ++ ++
G442A⁎ − − − − − −
Y443A − − − − − −
P444A − − − / / /
Residues that support the conformation of the α-fucose-binding site:
Q336A − − − / / /
T338A − − − − − −
S343A +/− ++ ++ +/− + +
H347A − − − / / /
The α-glactose/α-N-acetylglalactoseamine-binding site:
Q331A − + ++++ / / /
A346S⁎ − − − / / /
A346G⁎ +++ ++++ ++++ / / /
K348A⁎ − − ++++ / / /
I389A − − ++++ / / /
I389V + +++ ++++ / / /
S441A⁎ − − − / / /
β-Galactose-binding site:
D391A⁎ + +++ +++ / / /
2nd open cavity:
Q390A +/− +++ +++ / / /
G392A − + +++ / / /
N393A +/− +++ +++ / / /
H395A +/− ++ +++
Negative control:
T335S + ++++ ++++ / / /
M333A + ++++ ++++ / / /
R339A + ++++ ++++ + ++ ++
D517A + ++++ ++++ + ++ ++
S518A + ++++ ++++ + ++ ++
a Number of “+” indicated the relative binding afﬁnity of the mutant P particles and P
dimers to HBGAs. “−” indicated a complete loss of binding. /=not determined.
b The P particle formation of wild type and all mutants were conﬁrmed by gel
ﬁltration.
c Amino acids with a star symbol are predicted to interact with type A- and/or B-
trisaccharides by crystallographic study.
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might form an interaction interface speciﬁcally needed by the
A antigen.
Systematic analysis of residues in and around the binding interface
The ﬁndings of the two residues (Q331 and I389) that have no direct
contact with the trisaccharides but affect the receptor binding
suggested that a systematic analysis of individual residues in and
surrounding the HBGA-binding interface might be informative. The
crystal structure of the VA387 P dimer bound to the A- and B-
trisaccharides revealed eleven amino acids in the receptor-binding
interface that interact with the trisaccharide via direct or water-
mediated hydrogen bonds (Cao et al., 2007) (Fig. 1). We replaced all of
them with either alanines or serines, including the three residues
interacting with the α-1,3-glactose described above, and found thatFig. 2. Binding of mutant P particles with amino acid substitutions in or around the α-galact
different HBGAs (G–K). The X-axes of (A) to (F) show the protein concentrations of the P partic
value of triplicate experiments. “O”, “A”, and “B” represent the type O (containing H antig
oligosaccharides representing 9 different HBGAs (A, B, Lea, Leb, Lex, Ley, H1, H2, and H3). BSA i
(A-BSA and B-BSA), while the remaining oligosaccharides were conjugated to polyacrylamid
1 μg/ml and 2 μg/ml, respectively.the mutations affected HBGA-binding as predicted by the crystal
structures (see below).
In addition, 12 amino acids that have no direct contact with the
trisaccharides but surround the binding interface as shown by the
crystal structures (Fig. 1) were also subjected to mutagenesis. Many of
them also affected HBGA-binding (see below), indicating that these
residues are also required for the structural integrity of the receptor
binding interface. Finally, ﬁve other mutations (T335S, M333A, R339A,
D517A, and S518A) that are far away from the binding interface were
introduced into the P particles and none of them affected the HBGA-
binding function. None of the single amino-acid mutations described
in this study affected P particle or P dimer formation as shown by gel
ﬁltration analysis (Tan and Jiang, 2005b; Tan, Hegde, and Jiang, 2004;
Tan, Meller, and Jiang, 2006).
The α-fucose plays a central role in norovirus/receptor interactions
The crystal structures suggested six amino acids (T344, R345, A346,
D374, C440, and G442) interacting with the α-1,2-fucose of the B-
trisaccharide (Cao et al., 2007). These residues were replaced by
alanine or serine and 4 of the mutants lost their binding to all A-, B-,
and H- antigens completely or nearly completely (G442A) (Fig. 3 and
Table 2). The binding to HBGAs of the remaining 2 mutants (T344A and
C440A) did not change, although the crystal structures showed
hydrogen bonds between the two amino acids and the fucose (Fig.
1). This discrepancy could be explained by the fact that both residues
interact with the α-1,2-fucose through their backbone oxygen atoms
(Cao et al., 2007) (Fig. 1), which would remain the same in the
substituted alanines. Thus all six fucose-interacting amino acids
predicted by the crystal structures aremost likely required for binding
to the carbohydrate receptors.
In addition, seven other amino acids, none of which have contact
with the A- and B-trisaccharides, were also examined. Four (S343, Q336,
T338, and H347) of themwere suggested to support the conformation of
the α-fucose-binding site (Cao et al., 2007), while the other three
(N373, Y443, and P444) were nearby. Replacement of each of these seven
amino acids with alanines decreased binding to all A-, B- and H-
antigens signiﬁcantly (Fig. 4 and Table 2). Taken together, except the
six amino acids that have direct contact with the α-fucose, at least
seven additional residues are likely to be required for the structural
integrity of the binding site, further highlighting the importance of
this sugar in the norovirus/HBGA interaction as suggested by previous
studies (Cao et al., 2007; Huang et al., 2005; Tan and Jiang, 2005a; Tan
and Jiang, 2007).
The β-galactose may not be critical for HBGA-binding
The crystal structures indicated that the β-1,3-glalactose of both
type A- and B-trisaccharide is relatively distant from the P dimer
surface (Cao et al., 2007) (Fig. 1). Only D391 was seen to interact with
the β-galactose via two water-bridged hydrogen bonds (Fig. 1C).
However, replacement of D391 with an alanine only slightly reduced
binding to HBGAs (Fig. 5C and Table 1), suggesting that the interaction
between D391 and the β-1,3-glalactose may not be critical for binding
to HBGAs.
A nearby pocket affects binding to the A-antigen
Another open pocket near the binding interface that is made up of
residues Q390 and H395 in the bottom and D391, G392, N393 and Y443 asose-binding site to the saliva samples (A–F) and synthetic oligosaccharide representing
les and the Y-axes indicate the optical densities at 450 nm (OD450) that were the average
en), A, and B saliva, respectively. The X-axes of (G) to (K) shows a panel of synthetic
ndicates that those oligosaccharides were linked to bovine serum albumin as backbones
e (PAA) as backbones. The protein concentrations of VLP (G) and P particles (H–K) were
Fig. 3. Binding of mutant P particles with amino acid changes in or around the α-fucose-binding site to the saliva samples. The X-axes show the protein concentrations of the P
particles, while the Y-axes indicate the optical densities at 450 nm (OD450) that were the average value of triplicate experiments. “O”, “A”, and “B” represent the type O (containing H
antigen), A, and B saliva samples, respectively.
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with the HBGAs (Cao et al., 2007) (Fig. 1). When these residues were
replaced by alanines, except Y443 that has been shown to be important
for binding to A-, B-, and H-antigens probably by interacting with the
α-1,2-fucose (Fig. 3H), only G392 and H395 showed reduction in
binding to A- but not B-antigens (Figs. 5A to F). Interestingly, the
reduction in binding to A-antigen by G392A and H395A mutations
occurred only in the saliva- but not the synthetic oligosaccharide-
based binding assays (Figs. 5H to I). These data suggest that some
unknown features of the native HBGAs (saliva) that are missing on the
synthetic oligosaccharides may be responsible for the interactionwith
this nearby pocket.
The receptor binding interface is highly conserved among known
GII-4 viruses
Following the identiﬁcation of the receptor binding interface and
the functional involvement of the amino acids described above, we
performed a sequence alignment (Fig. 6A) of the major GII-4 variants,
including several strains with known binding patterns to all A-, B-and H-antigens and two strains that lost binding to all A-, B- and H-
antigens (Huang et al., 2003; Huang et al., 2005; Lindesmith et al.,
2008), in an attempt to elucidate the mechanism and residues that
are responsible for the receptor binding changes. Among the 19
amino acids (Fig. 6A and Table 1) important for HBGA-binding
identiﬁed in this study, only two amino acids have changed since
1987: A346 to a glycine (G) in 2000 and I389 to a valine (V) in 2001
(Fig. 6A). These are very similar amino acids with only a methyl
group (CH3) difference in their side chains between A and G or
between I and V. These changes appear not to correlate with the
phenotypic changes of the binding patterns (Huang et al., 2003;
Huang et al., 2005; Lindesmith et al., 2008). Mutant A346G developed
for VA387 did not affect the binding to types A and B saliva but
increased binding to type O saliva (Fig. 6C), mutant I389V showed a
small decrease in binding to type A but not B saliva (Fig. 6D), while
mutant with double mutations of A346G and I389V resulted in
stronger reduction in binding to both A- and B-antigens but the
bindings to all A-, B- and H-antigens clearly remained (Fig. 6E). These
data suggested that subtle changes of the binding interface can vary
receptor binding, but neither A346 nor I389 is responsible for the
Fig. 4. Binding of mutant P particles with single mutations at the 4 amino acids that were predicted to support the structural integrity of the α-fucose-binding site as well as 3 other
amino acids nearby. The X-axes show the protein concentrations of the P particles, while the Y-axes indicate the optical densities at 450 nm (OD450) that were the average value of
triplicate experiments. “O”, “A”, and “B” represent the type O (containing H antigen), A, and B saliva samples, respectively.
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viruses (Lindesmith et al., 2008).
Discussion
In this study we performed systematic mutagenesis on 27 amino
acids in and around the HBGA-binding interface of a GII-4 virus
(VA387) to examine their roles in norovirus-receptor binding afﬁnity
and speciﬁcity. Among 11 amino acid residues that have direct contact
with the carbohydrate receptors based on the crystal structures (Cao
et al., 2007), 7 residues are absolutely required for receptor-binding as
they knock out binding to both A- and B-antigens when they are
replaced by alanines. One residue (K348) is required for binding to A-
but not to B-antigens and the remaining three residues (T344, C440 and
D391) are also likely involved in the binding although the possibility
exists that we might not have selected proper replacement of aminoacids in our mutagenesis. In conclusion, except T344, C440, and D391,
whose roles for HBGA-binding remain to be conﬁrmed, all remaining 8
amino acids constituting the binding interface observed in the crystal
structure (Cao et al., 2007) participate in norovirus receptor binding.
In addition, we have identiﬁed another 11 amino acids that are
important for HBGA-binding, although they do not make direct
contact with the carbohydrate receptors according to the crystal
structures. These residues are likely responsible for the conforma-
tional integrity of the receptor binding interface. Finally, we have
demonstrated that the HBGA-binding interface is highly conserved
among the known GII-4 viruses, which is consistent with our
observation that the majority of GII-4 viruses bind to all A, B and H
antigens (unpublished data) and appear to explain their predomi-
nance in the epidemiology of noroviruses. However, we still cannot
exclude the possibility that additional residues other than those
described in this study are also involved in norovirus-HBGA binding
Table 2
Primers used for site-directed mutagenesis to generate single amino acid mutation
# Name Primer sequence (5′ to 3′) Sense Mutation
1 P981 CGTGGGAAAGATCGCAGGCATGCTCACCCAAACC + Q331A
2 P982 GGTTTGGGTGAGCATGCCTGCGATCTTTCCCCAG − Q331A
3 P983 GGGAAAGATCCAAGGCGCGCTCACCCAAACCAC + M333A
4 P984 GTGGTTTGGGTGAGCGCGCCTTGGATCTTTCCC − M333A
5 P1102 CAGTGAGCACTGGGACTGTCCACTTCACTCC + S335A
6 P1103 GGAGTGAAGTGGACAGTCCCAGTGCTCACTG − S335A
7 P985 CCAAGGCATGCTCACCGCAACCACAAGAGAGGATGGC + Q336A
8 P986 GCCATCCTCTCTTGTGGTTGCGGTGAGCATGCCTTGG − Q336A
9 P929 GCATGCTCACCCAAACCGCAAGAGAGGATGGCTCG + T338A
10 P930 CGAGCCATCCTCTCTTGCGGTTTGGGTGAGCATGC − T338A
11 P931 GCTCACCCAAACCACAGCAGAGGATGGCTCGACC + R339A
12 P932 GGTCGAGCCATCCTCTGCTGTGGTTTGGGTGAGC − R339A
13 P943 CACAAGAGAGGATGGCGCGACCCGCGCCCAC + S343A
14 P944 GTGGGCGCGGGTCGCGCCATCCTCTCTTGTG − S343A
15 P925 GAGAGGATGGCTCGGCCCGCGCCCACAAAGC + T344A
16 P926 GCTTTGTGGGCGCGGGCCGAGCCATCCTCTC − T344A
17 P927 GAGGATGGCTCGACCGCCGCCCACAAAGTTAC + R345A
18 P928 GTAGCTTTGTGGGCGGCGGTCGAGCCATCCTC − R345A
19 P991 GGATGGCTCGACCCGCTCCCACAAAGCTACAGTG + A346S
20 P992 CACTGTAGCTTTGTGGGAGCGGGTCGAGCCATCC − A346S
21 P1285 GGCTCGACCCGCGGCCACAAAGCTACAG + A346G
22 P1286 CTGTAGCTTTGTGGCCGCGGGTCGAGCC − A346G
23 P1100 GCTCGACCCGCGCCGCCAAAGCTACAGTGAGC + H347A
24 P1101 GCTCACTGTAGCTTTGGCGGCGCGGGTCGAGC − H347A
25 P1001 CGACCCGCGCCCACGCAGCTACAGTGAGCAC + K348A
26 P1002 GTGCTCACTGTAGCTGCGTGGGCGCGGGTCG − K348A
27 P993 CCACTGACACAAACGCTGATTTTCAAACTGGC + N373A
28 P994 GCCAGTTTGAAAATCAGCGTTTGTGTCAGTGG − N373A
29 P933 CACTGACACAAACAATGCTTTTCAAACTGGCC + D374A
30 P934 GGCCAGTTTGAAAAGCATTGTTTGTGTCAGTG − D374A
31 P995 GACACAAACAATGATGCTCAAACTGGCCAAAACACG + F375A
32 P996 CGTGTTTTGGCCAGTTTGAGCATCATTGTTTGTGTC − F375A
33 P1259 CACCCCAGTCGGCGTCGCCCAGGATGGTAATAACC + I389A
34 P1260 GGTTATTACCATCCTGGGCGACGCCGACTGGGGTG − I389A
35 P1287 CCCAGTCGGCGTCGTCCAGGATGGTAATAACC + I389V
36 P1288 GGTTATTACCATCCTGGACGACGCCGACTGGG − I389V
37 P1261 CCAGTCGGCGTCATCGCGGATGGTAATAACCACC + Q390A
38 P1262 GGTGGTTATTACCATCCGCGATGACGCCGACTGG − Q390A
39 P1106 CGGCGTCATCCAGGCTGGTAATAACCACC + D391A
40 P1107 GGTGGTTATTACCAGCCTGGATGACGCCG − D391A
41 P1263 GCGTCATCCAGGATGCTAATAACCACCAAAATG + G392A
42 P1264 CATTTTGGTGGTTATTAGCATCCTGGATGACGC − G392A
43 P1265 CGTCATCCAGGATGGTGCTAACCACCAAAATGAACC + N393A
44 P1266 GGTTCATTTTGGTGGTTAGCACCATCCTGGATGACG − N393A
45 P1267 CCAGGATGGTAATAACGCCCAAAATGAACCCCAGC + H395A
46 P1268 GCTGGGGTTCATTTTGGGCGTTATTACCATCCTGG − H395A
47 P1108 CCACTATGCCCGGGGCTAGCGGGTATCCC + C440A
48 P1109 GGGATACCCGCTAGCCCCGGGCATAGTCC − C440A
49 P1110 CTATGCCCGGGTGTGCCGGGTATCCCAAC + S441A
50 P1111 GTTGGGATACCCGGCACACCCGGGCATAG − S441A
51 P997 GCCCGGGTGTAGCGCGTATCCCAACATG + G442A
52 P998 CATGTTGGGATACGCGCTACACCCGGGC − G442A
53 P935 CCCGGGTGTAGCGGGGCTCCCAACATGAATCTGG + Y443A
54 P936 CCAGATTCATGTTGGGAGCCCCGCTACACCCGGG − Y443A
55 P999 GGGTGTAGCGGGTATGCCAACARGAATCTGG + P444A
56 P1000 CCAGATTCATGTTGGCATACCCGCTACACCC − P444A
57 P937 CCAATGGTTATTTTAGATTTGCTTCCTGGGTCAACCAG + D517A
58 P938 CTGGTTGACCCAGGAAGCAAATCTAAAATAACCATTGG − D517A
59 P939 GGTTATTTTAGATTTGATGCCTGGGTCAACCAGTTCTAC + S518A
60 P940 GTAGAACTGGTTGACCCAGGCATCAAATCTAAAATAACC − S518A
330 M. Tan et al. / Virology 379 (2008) 324–334because some GII-4 viruses lose complete or partial receptor-binding
but retain the conserved binding interface. Further investigations of
this issue are necessary.
Here we have provided direct evidence suggesting that the
acetamide group of the A antigen is responsible for the binding
speciﬁcity differences between the A and the B antigens. The
identiﬁcation of three amino acids (H348, Q331, and I389) responsible
for the binding speciﬁcity may help future genetic analysis and
classiﬁcation of noroviruses. For example, noroviruses differ in
recognizing the A and B antigens. VA387 (GII-4) described in this
study and a few other strains (MOH, MxV, and Paris Island virus)recognize both A and B antigens; the prototype Norwalk virus and
BUDS recognize A but not B; while the Snow Mountain virus
recognizes the B but not A antigen (Huang et al., 2005; Tan and
Jiang, 2005; Tan and Jiang, 2007; Tan et al., 2004). The identiﬁcation of
the site responsible for acetamide recognition on the capsid would
allow correlation between sequence and phenotype and consequently
allow a more detailed classiﬁcation of norovirus strains.
The demonstration of the involvement of the open pocket near
the binding interface in the HBGA interaction is also signiﬁcant since
it indicates that additional features of the HBGA molecules may also
participate in norovirus recognition. The involvement of this site in
binding to HBGAs was also observed previously through a mutant
VLP (D393G) of another GII-4 strain (Lindesmith et al., 2008). In
addition, the binding difference of the two mutants (G393A and
H395A) to the native HBGAs in saliva and synthetic carbohydrate
receptors (Fig. 5) further supports our hypothesis. The native HBGAs
are much more complicated containing 3 to 8 saccharides either free
or linked to proteins or lipids as backbones, while the synthetic
carbohydrates used in the crystallographic and the mutagenesis
studies contain only 2 to 4 sugars either free or linked to bovine
serum albumin (BSA) or polyacrylamide (PAA) as backbones. Thus
either additional sugars or the backbones of the native receptors
could be involved in the interaction with the nearby pocket. The
impact of the backbones in norovirus-receptor interaction has also
been previously suggested (Huang et al., 2005) but the site on the
viral capsid for this interaction remains unknown. The potential
interacting site of additional sugars could be investigated by co-
crystallization of the viruses or P dimers with more complicated
carbohydrate molecules.
Our study also provides new evidence supporting the central
role of the α-1,2-fucose- (H-epitope) in norovirus-host interaction
which was ﬁrst suggested by our previous characterization of
receptor binding variations of variable noroviruses (Huang et al.,
2003; Huang et al., 2005) and then by the crystal structure of a
GII-4 virus (Cao et al., 2007). Structurally the α-1,2-fucose is the
terminal saccharide of the H-related antigens, including A, B, Leb,
Ley, and H types 1, 2, 3 antigens, and thus is the key determinant
for binding to noroviruses. We now show functional evidence for
the requirement of the 6 residues interacting with the α-1,2-
fucose in GII-4 norovirus binding to all A-, B-, and H-antigens. In
addition, we demonstrated the involvement of a few other
residues interacting with the α-1,3-N-acetylglalactoseamine- (A-
epitope), which may further strengthen the binding afﬁnity and
determine the binding speciﬁcity. The complete loss of binding
activity to all A-, B- and H-antigens by single mutations in these
binding sites imply that they may be important targets for broadly
effective antivirals against different noroviruses with different
binding patterns.
The observed involvement of the acetamide of the A antigen in the
binding speciﬁcity of VA387 provides an example of how a minor
structural modiﬁcation of a HBGA can affect the receptor binding
pattern and potentially change the host range of a norovirus. Human
HBGA system is highly polymorphic under the control of multiple
gene families. In addition, modiﬁcations by other chemical groups
such as the sialic epitopes and subtypes of the ABO, secretor and Lewis
families of HBGAs make the human HBGA system and its recognition
with noroviruses even more complicated. The demonstration of the
relationship between the three amino acids (Q331, K348, and I389) and
the acetamide helps to explain the mechanism of the strain-speciﬁc
norovirus-HBGA interaction. Another example are the residues in the
nearby open cavity that could interact with additional structures of
HBGAs and reduce binding to the A-more than to the B-antigen [Fig. 5,
(Lindesmith et al., 2008)], although the detailedmechanism still needs
to be conﬁrmed.
In an attempt to explore the mechanism of the HBGA-binding
variations, evolution, and epidemiology of different GII-4 viruses
Fig. 5. Bindingofmutant P particleswith single amino acid change at the second openpocket to the saliva samples (A–F) and synthetic oligosaccharides representing differentHBGAs (G–J). The
X-axesof (A) to (F) showtheprotein concentrationsof thePparticles and theY-axes indicate theoptical densities at 450nm(OD450) thatwere theaveragevalueof triplicateexperiments. “O”, “A”,
and “B” represent the typeO (containingH antigen), A, andB saliva, respectively. TheX-axes of (G) to (J) shows a panel of synthetic oligosaccharides representing 9differentHBGAs (A, B, Lea, Leb,
Lex, Ley, H1,H2, andH3). BSA indicates that thoseoligosaccharideswere linked tobovine serumalbumin as backbones (A-BSAandB-BSA),while the remainingoligosaccharideswere conjugated
to polyacrylamide (PAA) as backbones. The protein concentrations of the P particles in G to J were 2 μg/ml. Mutant Q331A (J) served as control of selective inhibition of binding to A-antigen.
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Fig. 6. Sequence alignment (A) of the HBGA-binding interfaces and the surrounding regions in the P domain of GII-4 viruses selected from different years since 1987. Each virus is
indicated by the year of isolation and its accession number in the GenBank. Dark background indicates highly conserved residues and gray background represents less conserved
amino acids. Dots in the dark background indicate omission of conserved residues. The numbers on the top indicate the positions of the residues according to VA387 (underlined).
The Hunter virus (2004, DQ078794) and Sakai virus (2005, AB220922) that loss their binding activities (Lindesmith et al., 2008) are highlighted by bold letters. “#” indicates amino
acids that are required for HBGA-binding, “⁎” indicates residues that affect the binding speciﬁcity, “+” indicates amino acids that form the nearby open pocket and “b N” indicates the
boundary of the P1 and P2 subdomains. B to E, binding of mutant P particles of VA387 with single mutations [A346G (C) or I389V (D)], or double mutation [A346G and I389V (E)] to saliva
samples. The X-axes show the protein concentrations of the P particles (μg/ml) and the Y-axes indicate the optical densities at 450 nm (OD450) that were the average value of triplicate
experiments. “O”, “A”, and “B” represent the type O (containing H antigen), A, and B saliva, respectively.
332 M. Tan et al. / Virology 379 (2008) 324–334from different countries, we have shown that the majority of GII-4
strains isolated in the past 20 years retain a broad spectrum of host
speciﬁcity to all A, B and H antigens, although binding to each of the
antigen may be variable [(Huang et al., 2005), unpublished data]. In
this study we performed a sequence alignment of different GII-4
strains and found that 17 of the 19 amino acids that are critical for
HBGA-binding are highly conserved among all GII-4 viruses, while
the remaining two residues are replaced by very similar amino
acids. These data suggest that the human HBGAs might be a
selection marker in the evolution of noroviruses and our observa-tion that the majority of GII-4 viruses bind to all A, B and H antigens
(unpublished data) appears to explain the predominance of GII-4
viruses over other types that recognize narrower spectrum of
human HBGA receptors. Two mutations (A345G and I389V) affected
the binding speciﬁcity in a different way suggesting that a subtle
conformational change in the binding interface could result in
changes of the binding pattern. Unfortunately, we were unable to
identify any genetic markers responsible for the phenotypic change
of the GII-4 variants and the reason for the complete loss of binding
to the A, B and/or H antigens of Hunter and Sakai viruses
333M. Tan et al. / Virology 379 (2008) 324–334(Lindesmith et al., 2008) remains unknown. One possibility is that
residues other than those described in this study are also involved
in HBGA-binding of noroviruses. Those residues could directly
interact with the carbohydrate receptors by as yet unidentiﬁed
structures or be involved in deﬁning the local or global conforma-
tion that is required for the receptor binding function. One example
is the arginine cluster at the C-terminus of the P domain that is far
from the HBGA-binding interface but is required for receptor
binding (Tan, Meller, and Jiang, 2006). These issues will require
further structural and solution studies.
Materials and methods
Construction of mutant P particles and P dimers of VA387
The wild type P particle and the P dimer of VA387 were
constructed and expressed in bacteria as described previously (Tan
and Jiang, 2005b; Tan, Hegde, and Jiang, 2004; Tan, Meller, and Jiang,
2006). The mutant P particles and P dimers of VA387 with single
amino acid substitutions were constructed by site-directed mutagen-
esis using the expression constructs of P particle (P-RGD4C in pGEX-
4T-1) (Tan and Jiang, 2005b; Tan, Meller, and Jiang, 2006) or P dimer
(HP in pGEX-4T-1) (Tan and Jiang, 2005b; Tan, Hegde, and Jiang, 2004),
respectively, as templates. Site-directed mutagenesis was performed
using the QuickChange Site-Directed Mutagenesis Kit (Stratagen, La
Jolla, CA) and the corresponding primer pairs (Table 2) as described
elsewhere (Tan and Jiang, 2005b; Tan, Hegde, and Jiang, 2004; Tan,
Meller, and Jiang, 2006). The wild type and mutant P particles, as well
as P dimers, were expressed and puriﬁed as described previously (Tan
and Jiang, 2005b; Tan, Hegde, and Jiang, 2004; Tan, Meller, and Jiang,
2006). Brieﬂy, after sequence conﬁrmation through DNA sequencing,
the mutant constructs were expressed in E. coli strain BL21 with IPTG
(0.5 mM) induction at room temperature (∼25 °C) overnight. The P
protein-GST fusion proteins were puriﬁed using the Glutathione
Sepharose 4 ﬂow (GE Health Care Bio-Sciences, Piscataway, NJ)
according to the manufacturer's protocol. P proteins were released
from GST by thrombin (GE Health Care Bio-Sciences, Piscataway, NJ)
digestion. The formation of P particle and P dimer was determined by
gel ﬁltration using a size-exclusion column Superdex 200 (GE Health
Care Bio-Sciences, Piscataway, NJ) powered by an AKTA-FPLC system
(model 920, GE Health Care Bio-Sciences, Piscataway, NJ), inwhich the
P particles form a peak at ∼830 kDa and the P dimer at ∼69 kDa,
respectively (Tan and Jiang, 2005b; Tan, Hegde, and Jiang, 2004; Tan,
Meller, and Jiang, 2006).
HBGA binding assay
The saliva- and synthetic oligosaccharide-based binding assays
were performed basically as described elsewhere (Huang et al., 2003;
Huang et al., 2005). The afﬁnity-column puriﬁed P particles and P
dimers were ﬁrst diluted to 1 mg/ml as starting solutions, then they
were diluted further in a 3-fold-series to 33.3 μg/ml (30×), 11.1 μg/ml
(90×), 3.70 μg/ml (270×),1.23 μg/ml (810×), 0.41 μg/ml (2430×), 0.14 μg/
ml (7290×), 0.05 μg/ml (21,870×), 0.02 μg/ml (65,610×) directly on the
Elisa plates, on which saliva- or synthetic oligosaccharide have been
coated. Alternatively, the proteins were diluted to 10 μg/ml (100×),
3.3 μg/ml (300×), 1.1 μg/ml (900×), 0.37 μg/ml (2700×), 0.12 μg/ml
(8100×), 0.04 μg/ml (24,300×), 0.01 μg/ml (72,900×). The three saliva
samples used in this studywerewell-deﬁned in our laboratory (Huang
et al., 2003; Huang et al., 2005), each containing high level of A-, B-,
and H-antigen as determined by monoclonal antibodies against A, B,
H1, H2, H3 antigens (Signet Laboratories Inc, Dedham/MA). The
synthetic oligosaccharide-based binding assays were performed using
a panel of oligosaccharides representing 9 different HBGAs (A, B, H1,
H2, H3, Lea, Leb, Lex, and Ley) as reported previously (Huang et al.,
2003; Huang et al., 2005).Crystal structure visualization and analysis
The crystal structures of the P dimer of VA387 complexed with
type A- and B-trisaccharides were analyzed using the PyMOL software
(DeLano Scientiﬁc LLC, Palo Alto, CA) and the Polyview-3D server
(http://polyview.cchmc.org). The PDB ﬁles of the P protein in complex
with A-trisaccharide (2OBS) and with B-trisaccharide (2OBT) were
downloaded from the Protein Data Bank at the Rutgers University,
New Brunswick, NJ (http://www.rcsb.org).
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